Adverum Biotechnologies, Inc. Current Liabilities
Adverum Biotechnologies, Inc. had Current Liabilities of $44.75 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-11-12
- 2025-09-30: Liabilities, Current $44.75M.
- 2025-06-30: Liabilities, Current $31.36M.
- 2025-03-31: Liabilities, Current $25.09M.
- 2024-12-31: Liabilities, Current $22.90M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $44.75M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $31.36M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $25.09M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $22.90M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $22.61M 10-K · filed 2025-04-15 | $27.66M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $17.45M 10-K · filed 2025-04-15 | $22.46M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $16.58M 10-K · filed 2025-04-15 | $21.55M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $19.98M 10-K · filed 2025-04-15 | $24.91M 10-K · filed 2024-03-18 |
| 2023-09-30 | $23.96M 10-K · filed 2025-04-15 | $28.86M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $39.66M 10-K · filed 2025-04-15 | $44.52M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $40.94M 10-K · filed 2025-04-15 | $46.47M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $32.25M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $28.62M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $30.62M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $23.24M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $21.32M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $25.33M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $20.53M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $19.92M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $20.87M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $16.11M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $21.25M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $16.77M 10-Q · filed 2020-05-28 | |
| 2019-12-31 | $19.41M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $17.75M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $10.15M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $10.61M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $10.72M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $10.06M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $11.37M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $9.27M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $10.67M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $9.61M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $8.31M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $11.97M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $9.90M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $10.65M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $7.90M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $5.56M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $6.57M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $6.50M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $7.86M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $7.63M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $5.47M 10-K · filed 2016-03-04 | |
| 2014-09-30 | $4.46M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $3.99M 10-Q · filed 2014-09-12 | |
| 2013-12-31 | $1.16M 10-K · filed 2015-03-05 |